-
Founded in:
2000-02-29 -
Country:
China -
Address:
No. 219, Biquantan Road, Tianyi Economic Development Zone, Xiangtan, Hunan Province -
Tax NO.:
91430300740629832Q -
Registered Funds:
8.08 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| atriopeptin II |
|
98084-69-6 | 0 | |
| calcitonin gene related peptide |
|
0 | ||
| ADENOSINE 5'-TRIPHOSPHATASE |
|
9000-83-3 | 0 | |
| Adenosine |
|
58-61-7 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Policresulen |
No specific pharmacological information is provided
More
No specific pharmacological information is provided |
9011-02-3 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ammothamnine |
It has a significant effect on increasing the number of peripheral blood leukocytes in normal rabbits. The peak of the leukocyte count occurs on the 4th day after the first administration, which is 72% higher than before the administration, which is better than the leukocyte-raising drug shark liver alcohol. It has a significant effect on increasing leukocytes in rabbits induced by cobalt 60-gamma rays and deep X-ray irradiation. It also has a preventive effect on leukopenia when administered two days before irradiation. It can also prevent leukopenia in mice caused by mitomycin C. It has a synergistic inhibitory effect on solid Ehrlich carcinoma when used in combination with cyclophosphamide, and the toxicity of leukopenia caused by cyclophosphamide is significantly reduced.
More
It has a significant effect on increasing the number of peripheral blood leukocytes in normal rabbits. The peak of the leukocyte count occurs on the 4th day after the first administration, which is 72% higher than before the administration, which is better than the leukocyte-raising drug shark liver alcohol. It has a significant effect on increasing leukocytes in rabbits induced by cobalt 60-gamma rays and deep X-ray irradiation. It also has a preventive effect on leukopenia when administered two days before irradiation. It can also prevent leukopenia in mice caused by mitomycin C. It has a synergistic inhibitory effect on solid Ehrlich carcinoma when used in combination with cyclophosphamide, and the toxicity of leukopenia caused by cyclophosphamide is significantly reduced. |
16837-52-8 | 11 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Dihydroergotoxine mesylate |
It changes the signal transmission of the central nervous system, has an stimulatory effect on dopamine receptors and 5-hydroxytryptamine receptors, has a blocking effect on α-adrenergic receptors, improves damaged brain metabolic function, shortens cerebral circulation time, improves symptoms of intellectual decline, stabilizes cerebral vascular tension, and prevents migraines.
More
It changes the signal transmission of the central nervous system, has an stimulatory effect on dopamine receptors and 5-hydroxytryptamine receptors, has a blocking effect on α-adrenergic receptors, improves damaged brain metabolic function, shortens cerebral circulation time, improves symptoms of intellectual decline, stabilizes cerebral vascular tension, and prevents migraines. |
8067-24-1 | 13 | |
| Dihydroergocornine mesylate |
As a component of dihydroergotamine mesylate, they work together to improve brain metabolic function and stabilize cerebral vascular tone.
More
As a component of dihydroergotamine mesylate, they work together to improve brain metabolic function and stabilize cerebral vascular tone. |
0 | ||
| Dihydroergocryptine mesylate |
As a component of dihydroergotamine mesylate, they work together to improve brain metabolic function and stabilize cerebral vascular tone.
More
As a component of dihydroergotamine mesylate, they work together to improve brain metabolic function and stabilize cerebral vascular tone. |
0 | ||
| Dihydro-α-ergocryptine mesylate |
As one of the isomers of dihydroergocryptine mesylate, it is involved in improving brain metabolic function and stabilizing cerebral vascular tone.
More
As one of the isomers of dihydroergocryptine mesylate, it is involved in improving brain metabolic function and stabilizing cerebral vascular tone. |
0 | ||
| Dihydro-β-ergocryptine mesylate |
As one of the isomers of dihydroergocryptine mesylate, it is involved in improving brain metabolic function and stabilizing cerebral vascular tone.
More
As one of the isomers of dihydroergocryptine mesylate, it is involved in improving brain metabolic function and stabilizing cerebral vascular tone. |
0 | ||
| Dihydroergoline mesylate |
As a component of dihydroergotamine mesylate, they work together to improve brain metabolic function and stabilize cerebral vascular tone.
More
As a component of dihydroergotamine mesylate, they work together to improve brain metabolic function and stabilize cerebral vascular tone. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Tetracaine hydrochloride |
After entering the blood, most of it binds to plasma proteins and accumulates in tissues, with the largest accumulation in skeletal muscle. When the concentration in plasma decreases, it is released again. Most of it is hydrolyzed and converted by plasma cholinesterase, metabolized by the liver into p-aminobenzoic acid and dimethylaminoethanol, and then degraded or combined and excreted in the urine.
More
After entering the blood, most of it binds to plasma proteins and accumulates in tissues, with the largest accumulation in skeletal muscle. When the concentration in plasma decreases, it is released again. Most of it is hydrolyzed and converted by plasma cholinesterase, metabolized by the liver into p-aminobenzoic acid and dimethylaminoethanol, and then degraded or combined and excreted in the urine. |
136-47-0 | 16 |